China A-share traditional Chinese medicine sector rose against the market.
Lingrui Pharmaceutical and Guilin Sanjin hit the daily upper limit; Xinbang
Pharmaceutical, Buchang Pharmaceutical, Kuihua Pharmaceutical, Jilin Aodong and
Kangmei Pharmaceutical each advanced more than 3%.